ARCT:NASDAQ, Arcturus Therapeutics Holdings Inc.

ARCT stock overview

Arcturus Therapeutics Holdings Inc. (ARCT:NASDAQ) closed at $10.79 on October 22, 2026, down 2.53% on the day. The stock trades 39.9% below its 52-week high of $17.96 and 96.2% above its 52-week low of $5.50. Over the past year, it lost 4.1%. Arcturus Therapeutics Holdings Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$10.79
Day change
-2.53%
Volume
24,480
Average volume
944,559
Market cap
306M+
52-week range
$5.50 – $17.96
50-day average
$13.30
200-day average
$8.87

Price action over the past year

In 252 trading sessions since October 21, 2025, ARCT closed higher on 121 days (48%). Its best day was August 19, 2026 (+25.21%) and its worst was October 22, 2025 (-50.17%). The stock moved 10% or more in a single session 8 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

ARCT news

About Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Ltd is a biotechnology company developing novel RNA medicines. The company develops novel RNA medicines in therapeutic areas including infectious disease, cystic fibrosis, nonalcoholic steatohepatitis (NASH) and rare liver diseases.

Similar stocks

Find more stocks like ARCT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.